Published in Antimicrob Agents Chemother on December 01, 2004
Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev (2007) 2.66
Silencing of glycopeptide resistance in Enterococcus faecalis BM4405 by novobiocin. Antimicrob Agents Chemother (2005) 0.75
Communication modules in bacterial signaling proteins. Annu Rev Genet (1992) 14.32
Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis (1989) 4.55
Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob Agents Chemother (1992) 3.63
Glycopeptide resistance in enterococci. Trends Microbiol (1996) 3.42
Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol Microbiol (1994) 2.90
Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol Microbiol (1996) 2.84
Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother (1994) 2.65
VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother (1997) 2.50
Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci. FEMS Microbiol Lett (1992) 2.35
Mutations that alter the kinase and phosphatase activities of the two-component sensor EnvZ. J Bacteriol (1998) 2.19
The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction. J Bacteriol (1997) 2.19
Purification and characterization of VanR and the cytosolic domain of VanS: a two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147. Biochemistry (1993) 1.99
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother (1999) 1.95
Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother (2000) 1.79
The vanG glycopeptide resistance operon from Enterococcus faecalis revisited. Mol Microbiol (2003) 1.64
Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol (1997) 1.60
A six amino acid deletion, partially overlapping the VanSB G2 ATP-binding motif, leads to constitutive glycopeptide resistance in VanB-type Enterococcus faecium. Mol Microbiol (2003) 1.24
Mechanisms of glycopeptide resistance in enterococci. J Infect (1996) 1.10
The role of the G2 box, a conserved motif in the histidine kinase superfamily, in modulating the function of EnvZ. Mol Microbiol (2002) 1.05
Molecular characterization of the vanE gene cluster in vancomycin-resistant Enterococcus faecalis N00-410 isolated in Canada. Antimicrob Agents Chemother (2002) 1.01
vanE gene cluster of vancomycin-resistant Enterococcus faecalis BM4405. J Bacteriol (2002) 1.00
Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol (2004) 1.00
The VanY(D) DD-carboxypeptidase of Enterococcus faecium BM4339 is a penicillin-binding protein. Microbiology (2001) 0.92
Identification of the first vancomycin-resistant Enterococcus faecalis harbouring vanE in Canada. Can Commun Dis Rep (2001) 0.85
Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis (2007) 3.98
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother (2003) 3.22
Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis (2005) 3.18
Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother (2004) 2.89
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob Agents Chemother (2007) 2.67
Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev (2007) 2.66
ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum beta-lactamase CTX-M-17. Antimicrob Agents Chemother (2002) 2.21
Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother (2002) 2.17
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog (2011) 2.15
Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J Clin Microbiol (2004) 2.07
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 2.04
Resistance of Yersinia pestis to antimicrobial agents. Antimicrob Agents Chemother (2006) 1.97
Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis (2008) 1.96
Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother (2002) 1.94
Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother (2010) 1.89
armA and aminoglycoside resistance in Escherichia coli. Emerg Infect Dis (2005) 1.70
VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 1.64
The vanG glycopeptide resistance operon from Enterococcus faecalis revisited. Mol Microbiol (2003) 1.64
Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.58
Glycopeptide antibiotics: from conventional molecules to new derivatives. Drugs (2004) 1.56
Antibiotic use and resistance--proving the obvious. Lancet (2005) 1.51
Revised nomenclature for transposable genetic elements. Plasmid (2008) 1.50
RmtF, a new member of the aminoglycoside resistance 16S rRNA N7 G1405 methyltransferase family. Antimicrob Agents Chemother (2012) 1.49
Aminoglycoside resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens. J Mol Biol (2006) 1.48
Sequence of conjugative plasmid pIP1206 mediating resistance to aminoglycosides by 16S rRNA methylation and to hydrophilic fluoroquinolones by efflux. Antimicrob Agents Chemother (2008) 1.44
Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc Natl Acad Sci U S A (2010) 1.44
European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. J Antimicrob Chemother (2003) 1.40
Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 1.38
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray. Antimicrob Agents Chemother (2009) 1.36
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.36
Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections. J Infect Dis (2013) 1.32
A six amino acid deletion, partially overlapping the VanSB G2 ATP-binding motif, leads to constitutive glycopeptide resistance in VanB-type Enterococcus faecium. Mol Microbiol (2003) 1.24
VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother (2004) 1.22
Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob Agents Chemother (2005) 1.22
Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob Agents Chemother (2003) 1.22
RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother (2013) 1.20
D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother (2011) 1.20
Emergence of IMP-4 metallo-beta-lactamase in a clinical isolate from Australia. J Antimicrob Chemother (2004) 1.19
Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine. Antimicrob Agents Chemother (2005) 1.19
Selection of SHV extended-spectrum-beta-lactamase-dependent cefotaxime and ceftazidime resistance in Klebsiella pneumoniae requires a plasmid-borne blaSHV gene. Antimicrob Agents Chemother (2007) 1.17
Structural bases for 16 S rRNA methylation catalyzed by ArmA and RmtB methyltransferases. J Mol Biol (2009) 1.17
Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon. Antimicrob Agents Chemother (2006) 1.17
rpoB mutation conferring rifampin resistance in Streptococcus pyogenes. Antimicrob Agents Chemother (2002) 1.15
Acquisition of multidrug resistance transposon Tn6061 and IS6100-mediated large chromosomal inversions in Pseudomonas aeruginosa clinical isolates. Microbiology (2010) 1.12
Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect Immun (2005) 1.10
VanD-type vancomycin-resistant Enterococcus faecium 10/96A. Antimicrob Agents Chemother (2003) 1.09
Genetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia. Antimicrob Agents Chemother (2012) 1.08
Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2004) 1.08
Organic and conventional fruits and vegetables contain equivalent counts of Gram-negative bacteria expressing resistance to antibacterial agents. Environ Microbiol (2009) 1.08
Expert systems in clinical microbiology. Clin Microbiol Rev (2011) 1.07
Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA). Int J Antimicrob Agents (2012) 1.05
The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis (2002) 1.04
Expression of the resistance-nodulation-cell division pump AdeIJK in Acinetobacter baumannii is regulated by AdeN, a TetR-type regulator. Antimicrob Agents Chemother (2012) 1.04
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008). J Infect (2010) 1.03
An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae. J Antimicrob Chemother (2004) 1.03
Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. J Med Microbiol (2010) 1.01
vanE gene cluster of vancomycin-resistant Enterococcus faecalis BM4405. J Bacteriol (2002) 1.00
Wild-type intracellular bacteria deliver DNA into mammalian cells. Cell Microbiol (2002) 0.97
Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia. Diagn Microbiol Infect Dis (2006) 0.96
Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. J Antimicrob Chemother (2010) 0.95
Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob Agents Chemother (2004) 0.95
Binding sites of VanRB and sigma70 RNA polymerase in the vanB vancomycin resistance operon of Enterococcus faecium BM4524. Mol Microbiol (2005) 0.95
parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513. Antimicrob Agents Chemother (2002) 0.95
Antimicrobial resistance of Listeria monocytogenes isolates from food and the environment in France over a 10-year period. Appl Environ Microbiol (2011) 0.94
Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing enterobacteriaceae in Morocco. J Infect Dev Ctries (2010) 0.93
Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure. MBio (2014) 0.93
An emptying quiver: antimicrobial drugs and resistance. Emerg Infect Dis (2005) 0.93
Comparison of four methods, including semi-automated rep-PCR, for the typing of vancomycin-resistant Enterococcus faecium. J Microbiol Methods (2010) 0.92
Aminoglycoside resistance gene ant(4')-IIb of Pseudomonas aeruginosa BM4492, a clinical isolate from Bulgaria. Antimicrob Agents Chemother (2003) 0.92
Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp. Antimicrob Agents Chemother (2013) 0.92
Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria. Clin Microbiol Infect (1996) 0.91
VanA-mediated high level glycopeptide resistance in MRSA. Lancet Infect Dis (2003) 0.91
Structural basis of Synercid (quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens. J Biol Chem (2003) 0.90
Methicillin-resistant Staphylococcus aureus, Western Australia. Emerg Infect Dis (2005) 0.90
Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis. Antimicrob Agents Chemother (2006) 0.90
VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on vancomycin for growth. Antimicrob Agents Chemother (2009) 0.89
Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil. Antimicrob Agents Chemother (2005) 0.89
Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Int J Antimicrob Agents (2002) 0.88
The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance. Mol Microbiol (2013) 0.88
RAHN-2, a chromosomal extended-spectrum class A beta-lactamase from Rahnella aquatilis. J Antimicrob Chemother (2010) 0.87
Resistance phenotypes conferred by macrolide phosphotransferases. FEMS Microbiol Lett (2007) 0.87
Chromosomal aadD2 encodes an aminoglycoside nucleotidyltransferase in Bacillus clausii. Antimicrob Agents Chemother (2003) 0.85
Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin. Antimicrob Agents Chemother (2008) 0.85
Transcriptional analysis of the vanC cluster from Enterococcus gallinarum strains with constitutive and inducible vancomycin resistance. Antimicrob Agents Chemother (2005) 0.85
Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations. J Cyst Fibros (2006) 0.85
Eukaryotic promoters can direct protein synthesis in Gram-negative bacteria. J Mol Microbiol Biotechnol (2003) 0.84
Emergence of carbapenem-resistant Hafnia: the fall of the last soldier. Clin Infect Dis (2010) 0.84
Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa. J Antimicrob Chemother (2011) 0.84
TEM-103/IRT-28 beta-lactamase, a new TEM variant produced by Escherichia coli BM4511. Antimicrob Agents Chemother (2002) 0.83
Structural and functional characterization of VanG D-Ala:D-Ser ligase associated with vancomycin resistance in Enterococcus faecalis. J Biol Chem (2012) 0.83
Structural basis for the evolution of vancomycin resistance D,D-peptidases. Proc Natl Acad Sci U S A (2014) 0.83
Functional motions modulating VanA ligand binding unraveled by self-organizing maps. J Chem Inf Model (2014) 0.82